Code | 7278E | ||||||||||
MA number | 44/0222/24-S | ||||||||||
Product Form: | cps dur 28x150 mg (blis.PVC/PE/PVDC/Al) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | STADA Arzneimittel AG, Germany | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 27.08.2024 |
Validity: | 27.08.2029 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
SPC: | SPC_Nilotinib STADA 150 mg tvrdé kapsuly_09.2024.pdf |
PIL: | PIL_Nilotinib STADA 150 mg tvrdé kapsuly_09.2024.pdf |
Safety feature | Yes |
Data update: | 05.09.2024 |